Abbott (ABT) Reports In-Line Q4 EPS; offers guidance
Get Alerts ABT Hot Sheet
Price: $115.37 +1.08%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $1.50, in-line with the analyst estimate of $1.50. Revenue for the quarter came in at $11.46 billion versus the consensus estimate of $11.8 billion.
GUIDANCE:
Abbott sees Q1 2026 EPS of $1.12-$1.18, versus the consensus of $1.20.
Abbott sees FY2026 EPS of $5.55-$5.80, versus the consensus of $5.17.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- LivePerson extends special meeting deadline for SoundHound AI merger vote
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share